Preoperative Guided Imagery in Patients Undergoing Urologic Surgery

Status Completed

Clinical Trial Summary

This is a prospective randomized controlled trial of patients undergoing major urologic-oncologic surgery at the University of California, San Francisco (UCSF) Medical Center and the Helen Diller Family Comprehensive Cancer Center. This clinical trial examines the effect of guided meditation before surgery on the levels of anxiety, stress, sleep disturbance, and quality of life among patients scheduled to undergo a major urologic surgery for cancer. A cancer diagnosis and the treatments associated with it can be very stressful for patients, leading to depression, sleep disturbances, and lower quality of life. Mind-body practices such as guided meditation have been used for thousands of years to reduce the effects of chronic stress and to improve quality of life. This clinical trial examines the effects of guided meditation on the stress, depression, and quality of life levels of patients undergoing urologic surgery for their cancer.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To determine the effect of 14 days of preoperative guided visualization meditation on patients' anxiety undergoing major urologic-oncology surgery. SECONDARY OBJECTIVES: I. To determine the effect of preoperative guided visualization meditation on patients' depression, stress, and quality of life. II. To examine the difference in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey question scores between the two study groups. III. To determine the ability of patient to perform a daily 23 minute meditation. IV. To examine the correlation between depression and emergency department (ED) visits and readmissions post-operations. OUTLINE: Patients are randomized to 1 of 2 arms. ARM 1: Patients listen to guided meditation over 23 minutes daily for two weeks before their standard of care surgery. Patients also complete surveys over 10-15 minutes at baseline, after 10 days, 1 day before standard of care surgery, the day after discharge, and then 4 weeks after surgery. ARM 2: Patients complete surveys over 10-15 minutes at baseline, after 10 days, 1 day before standard of care surgery, the day after discharge, and then 4 weeks after surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05072639
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	March 25, 2017
Completion date	September 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06397287` - PROM Project Urology
Active, not recruiting	`NCT04840511` - The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping	N/A
Not yet recruiting	`NCT06398314` - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors	N/A
Completed	`NCT04933604` - LPN in Patients With High-complex Renal Tumors
Recruiting	`NCT06187870` - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Recruiting	`NCT05726136` - Fluid Challenge and Plasma Volume, During Surgery	Phase 4
Not yet recruiting	`NCT03715855` - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples	N/A
Recruiting	`NCT04931979` - SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy	Phase 2
Terminated	`NCT03721042` - Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples	N/A
Recruiting	`NCT05913245` - Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy	N/A
Active, not recruiting	`NCT05169437` - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors	Phase 2
Completed	`NCT04213157` - Laparoscopic Partial Nephrectomy for cT1 Tumors
Not yet recruiting	`NCT06282354` - Telemedicine for Postoperative Follow-up After Oncological Surgeries
Completed	`NCT04720599` - Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
Recruiting	`NCT00294476` - IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma	Phase 2
Completed	`NCT03602079` - Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene	Phase 1/Phase 2
Recruiting	`NCT05725304` - The Registry of Genetic Expression of Taiwan Urologic Cancer
Not yet recruiting	`NCT05920343` - VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy	Phase 2/Phase 3
Completed	`NCT03245788` - Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study	N/A
Recruiting	`NCT04702347` - Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.